Abiopharma

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

Notification from BriaCell Therapeutics Corp.

SWE’s Most Popular Content of 2025

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

UTHR: Notification

UTHR: Notification

Zoetis - Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares